Extrapulmonary Spectrum of Invasive Pneumococcal Disease

Affiliations

¹ Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre (APC), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
² Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre (APC), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. ny.karthi@gmail.com.

Jyothi Jayaram et al. Indian J Pediatr. 2025 Feb.

. 2025 Feb;92(2):211.

doi: 10.1007/s12098-024-05360-2. Epub 2024 Dec 14.

¹ Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre (APC), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
² Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatric Centre (APC), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. ny.karthi@gmail.com.

No abstract available

Conflict of interest statement

Declarations. Conflict of Interest: None.

1. World Health Organization. WHO position paper on pneumococcal conjugate vaccines in infants and children under 5 years of age. Wkly Epidemiol Record. 2019 [Internet]. Available at: https://apps.who.int/iris/bitstream/handle/10665/310968/WER9408.pdf?ua=1 . Accessed 15 Nov 2024.
1. Bertran M, Amin-Chowdhury Z, Sheppard CL, et al. Increased incidence of invasive pneumococcal disease among children after COVID-19 pandemic. England Emerg Infect Dis. 2022;28:1669–72. - DOI - PubMed
1. Grant LR, Slack MPE, Theilacker C, et al. Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination. Clin Infect Dis. 2023;76:e1062–70. - DOI - PubMed
1. Wang JL, Lai CC, Ko WC, Hsueh PR. Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016–21. Int J Antimicrob Agents. 2024;63:107072. - DOI - PubMed